
P154 SAFETY AND TOLERABILITY OF ONCE-DAILY ORAL KALLIKREIN INHIBITOR BCX7353 IN PHASE 3 APEX-2 HAE STUDY
Riedl, M., Lumry, W., Banerji, A., Aygoren-Pursun, E., Bernstein, J., Maurer, M., Cicardi, M., Christiansen, S., Zuraw, B., Dobo, S., Cornpropst, M., Iocca, H., Nagy, E., Murray, S., Collis, P., SheriVolume:
123
Langue:
english
Journal:
Annals of Allergy, Asthma & Immunology
DOI:
10.1016/j.anai.2019.08.258
Date:
November, 2019
Fichier:
PDF, 764 KB
english, 2019